Key Role for Respiratory CD103+ Dendritic Cells, IFN- , and IL-17 in Protection Against Streptococcus Pneumoniae Infection in Response to -Galactosylceramide

Stoyan Ivanov,Josette Fontaine,Christophe Paget,Elodie Macho Fernandez,Laurye Van Maele,Joelle Renneson,Isabelle Maillet,Natalia Munoz Wolf,Analia Rial,Helene Leger,Bernard Ryffel,Benoit Frisch,Jose A. Chabalgoity,Jean Claude Sirard,Arndt Benecke,Christelle Faveeuw,Francois Trottein
DOI: https://doi.org/10.1093/infdis/jis413
2012-01-01
Abstract:Background. Exogenous activation of pulmonary invariant natural killer T (iNKT) cells, a population of lipid-reactive alpha beta T lymphocytes, with use of mucosal alpha-galactosylceramide (alpha-GalCer) administration, is a promising approach to control respiratory bacterial infections. We undertook the present study to characterize mechanisms leading to alpha-GalCer-mediated protection against lethal infection with Streptococcus pneumoniae serotype 1, a major respiratory pathogen in humans.Methods and Results.alpha-GalCer was administered by the intranasal route before infection with S. pneumoniae. We showed that respiratory dendritic cells (DCs), most likely the CD103(+) subset, play a major role in the activation (IFN-gamma and IL-17 release) of pulmonary iNKT cells, whereas alveolar and interstitial macrophages are minor players. After challenge, S. pneumoniae was rapidly (4 hours) eliminated in the alveolar spaces, a phenomenon that depended on respiratory DCs and neutrophils, but not macrophages, and on the early production of both IFN-gamma and IL-17. Protection was also associated with the synthesis of various interferon-dependent and IL-17-associated genes as revealed by transcriptomic analysis.Conclusions.These data imply a new function for pulmonary CD103(+) DCs in mucosal activation of iNKT cells and establish a critical role for both IFN-gamma and IL-17 signalling pathways in mediating the innate immune response to S. pneumoniae.
What problem does this paper attempt to address?